The Canadian Securities Exchange launched a new index meant to account for the largest companies on the exchange, some of the top weighing companies in the index operate in the cannabis business.
Released earlier this week (September 18), the exchange indicated the companies on thr index, called CSE25, represent over 50 percent of the “weighting in the larger index.”
“[I]t is appropriate that we give market participants a benchmark that monitors the performance of our largest and most liquid issues,” Richard Carleton, CEO of the CSE said in the release.
Here the Investing News Network takes a look at the top cannabis companies included in the index and their current weight as indicated by the CSE.

Liberty Health Sciences (CSE:LHS) 14.31 percent weight

Liberty Health Sciences is a partner company of Aphria (TSX:APH), a licensed producer (LP) focused on the medical market in Canada. Liberty Health on the other hand seeks to gain market share in the US, initially in the state of Florida.
Following the impact of Hurricane Irma in Florida, the company told shareholders its facilities in the state had suffered no structural damage damage to its facilities in the area had been secured. Liberty Health also recently announced it had secured two new medical cannabis dispensaries facilities, set to open later this year.


CannTrust Holdings (CSE:TRST) 13 percent weight

CannTrust is an LP offering medical users a variety of oils, dried cannabis and even vaporizers. The company plans to expand their production with a 430,000-square foot greenhouse.
Most recently the company released its financial report for the three and six month periods which ended on June 30, in which CannTrust highlighted a $4.5 million in revenue for their second quarter compared to the year before.
“Our recent listing on the CSE will provide the Company with the exposure, platform and access to capital markets required to effectively compete and participate in the dynamic growth of our industry,” chief executive officer Eric Paul said regarding the company’s launch on the CSE in August 21.

Alternate Health (CSE:AHG) 5.69 percent percent weight

Alternate Health is an international medical cannabis company seeking to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices. As part of their most recent quarterly report, the company announced a $7.2 million in revenue.
Dr. Michael Murphy, chief executive officer of the company said their listing on this new index was a sign of their current momentum.

Maricann (CSE:MARI) 4.90 percent weight

Maricann is a producer and distributor of medical cannabis. The company’s first phase of a 217,000 square feet expansion is set to be inspected by Health Canada in November.
On September 5, the company announced it had secured a second sales license for its Burlington, Ontario location.
“The new headquarters in Burlington will centralize our sales, marketing and customer services operations under one roof… In the near future, we expect to conduct analytical testing and bench research onsite.”

CannaRoyalty (CSE:CRZ) 4.11 percent weight

CannaRoyalty operates as an investor and operator focused in the legal cannabis sector including several holdings and what the company calls “CR Brands,” wholly owned and licensed brands that cover high growth segments.
As part of their second quarter release CannaRoyalty reported total assets worth $50,018,351. It’s product sales for the six first months of the year totaled $404,328, while its total revenue for the second quarter of the year amounted to 960,157.
“In the coming months, we will continue to add to our portfolio in key focus areas while leveraging the strength of our CR Advisory and CR Brands divisions,” chief executive officer Marc Lustig said in the company’s press release.
Don’t forget to follow us @INN_LifeScience and @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less